Bicarbonate

Bicarbonate

SCHEMBL20423841

CC(C)=C(F)F.O=C(O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
CA1 P00915 3/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
LMNA P02545 3/20 0.39
TSHR P16473 1/20 0.36
THPO P40225 1/20 0.36
ALOX15 P16050 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
SLC15A2 Q16348 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL20423710 0.83 FFAR3 (0.46) FFAR3LCKFYNCA1CA2
Bicarbonate SCHEMBL10180649 0.83 FFAR3 (0.46) FFAR3LCKFYNCA1CA2
SCHEMBL1828737 0.82
Tetrafluoroethylene SCHEMBL27662225 0.78 LMNA (0.42) FFAR3LCKFYNCA1CA2
Bicarbonate SCHEMBL27793478 0.78 FFAR3 (0.50) FFAR3LCKFYNCA1CA2
Tetrafluoroethylene SCHEMBL28004090 0.78 FFAR3 (0.64) FFAR3LCKFYNCA1CA2
Bicarbonate SCHEMBL1058643 0.78 FFAR3 (0.50) FFAR3LCKFYNCA1CA2
Tetrafluoroethylene SCHEMBL321363 0.77 CA1 (0.56) FFAR3LCKFYNCA1CA2
Bicarbonate SCHEMBL4832988 0.77 FFAR3 (0.60) FFAR3LCKFYNCA1CA2
Tetrafluoroethylene SCHEMBL28869053 0.77 CA1 (0.56) FFAR3LCKFYNCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113273011-A Electrolyte solution, electrochemical device, and electronic device 宁德新能源科技有限公司 2021-08-17 CN disclosed
US-11043699-B2 Nonaqueous electrolyte solution and method for producing nonaqueous electrolyte secondary battery TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2021-06-22 US disclosed
US-20180219259-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SECONDARY BATTERY TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11043699-B2 Nonaqueous electrolyte solution and method for producing nonaqueous electrolyte secondary battery NAF1, CA2, CA1 FFAR3 3077/4885LCK 3570/4885FYN 2540/4885
US-20180219259-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SECONDARY BATTERY NAF1, CA2, CA1 FFAR3 3077/4885LCK 3570/4885FYN 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.